Sullivan Mark's Form 4 filing
Definium Therapeutics, Inc. (DFTX) · filed Sep 25, 2024
- Accession no.
- 0000950170-24-109447
- Filed
- Sep 25, 2024
- Trade date
- Sep 25, 2024
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $26.5K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sullivan MarkCIK 0001331843 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 25, 2024 | Common Shares | SSaleDisposed | −4,430 | $5.98 | −$26,491.4 | 177,716 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.